Global Non-Surgical Procedures Market - Industry Trends and Forecast to 2030

Get Exclusive Sample PDF of this Report Here

Non-Surgical Procedures Market Analysis and Size

Non-surgical procedures typically involve less invasive techniques compared to traditional surgical options. This appeals to patients who are looking for aesthetic or medical improvements without the risks, pain, and recovery time associated with surgery. Ongoing advancements in medical and cosmetic technologies have led to the development of more effective and less invasive procedures. Innovations such as laser technology, radiofrequency, and ultrasound have expanded the range of available non-surgical treatments. Non-surgical procedures often have a lower risk of complications compared to surgical interventions. This factor can boost patient confidence and encourage them to seek non-surgical options.

Data Bridge Market Research analyses that the global non-surgical procedures market  which was USD 61,200.00 million in 2022, would rocket up to USD 192,485.44 million by 2030, and is expected to undergo a CAGR of 15.4% during the forecast period. This indicates the market value. “Injectable” dominates the product type segment of the global non-surgical procedures market owing to the increasing investment in healthcare. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Non-Surgical Procedures Market Scope and Segmentation

Get Exclusive Sample PDF of this Report Here

市场定义

全球非手术程序市场是医疗保健和美容行业的一部分，专注于非侵入性或微创医疗和美容治疗。这些程序旨在改善或恢复一个人外貌的各个方面，或解决特定的医疗状况，而无需进行涉及切口和延长恢复时间的传统手术。相反，它们通常涉及使用医疗设备、注射剂或其他可以在门诊、诊所或医疗水疗中心进行的技术。

全球非手术程序市场动态

驱动程序

• 美容需求不断增长

随着人们对改善外貌的渴望日益增长，社交媒体和美容标准的影响也推动了对非手术美容程序的需求，例如皮肤填充剂、肉毒杆菌和非手术面部提升术

• 技术进步

激光和基于能量的设备等持续的技术创新扩大了可用的非手术治疗范围，使其更有效、更有吸引力

机会

• 产品开发创新

公司有机会开发更持久、更有效的非手术治疗方法，从而减少频繁补妆的需要

此外，市场参与者之间不断增加的合作、合并和收购将在 2023 年至 2030 年的预测期内为市场参与者带来盈利机会。此外，市场参与者数量的增加将进一步扩大未来市场的增长率

克制/挑战

• 监管障碍

监管审批和合规性可能很复杂，不同地区的监管严格程度各不相同，影响市场准入和产品开发

另一方面，预计与产品制造相关的高成本将阻碍市场增长。此外，供应链行业的中断可能会对市场的增长构成挑战。此外，在 2023-2030 年的预测期内，发展中经济体缺乏有利的报销方案和技术渗透以及缺乏合适的基础设施预计将对市场构成挑战

这份全球非手术程序市场报告提供了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响的详细信息，分析了新兴收入领域的机会、市场法规的变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地域扩展、市场技术创新。如需了解有关全球非手术程序市场的更多信息，请联系 Data Bridge Market Research 获取分析师简报，我们的团队将帮助您做出明智的市场决策，实现市场增长

近期发展

• 2020 年 9 月，Croma Deutschland GmbH 宣布与中国生物技术集团有限公司成立合资企业，在中国和香港销售其优质透明质酸填充剂 Princess 系列以及 Croma 的各种其他美容产品，这是该合资企业的主要目的

全球非手术程序市场范围

全球非手术程序市场根据产品类型、材料类型、性别、可用性、适应症、程序、从业者、服务提供商和分销渠道进行细分。这些细分市场之间的增长将帮助您分析行业中增长微弱的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。

产品类型

• 注射剂
• 非注射剂
• 面部年轻化
• 非手术皮肤紧致
• 微晶磨皮
• 激光换肤
• 其他的

材质类型

• 自然的
• 合成的

性别

• 男性
• 女性

可用性

• 专业用途
• 直接患者

指征

• 皮肤美白
• 面部美容
• 身体塑形
• 重建
• 其他的

程序

• 身体护理
• 面部护理
• 皮肤护理

执业医师

• 皮肤科医生
• 美容医生
• 整形外科医生
• 独立美容专业人士
• 其他的

服务提供商

• 医院
• 医疗水疗 和美容中心
• 美容中心
• 皮肤科诊所
• 家庭护理环境
• 其他的

分销渠道

• 直接招标
• 零售销售

全球非手术程序市场区域分析/见解

对全球非手术程序市场进行了分析，并按上述产品类型、材料类型、性别、可用性、适应症、程序、从业者、服务提供商和分销渠道提供了市场规模洞察和趋势。

全球非手术程序市场报告涵盖的国家包括美国、加拿大、墨西哥、英国、德国、法国、西班牙、意大利、荷兰、瑞士、俄罗斯、比利时、土耳其、欧洲其他地区、中国、韩国、日本、印度、澳大利亚、新加坡、马来西亚、印度尼西亚、泰国、菲律宾、亚太其他地区、南非、沙特阿拉伯、阿联酋、埃及、以色列、中东和非洲其他地区、巴西、阿根廷和南美洲其他地区

北美在市场份额和市场收入方面占据非手术程序市场的主导地位，并将在预测期内继续保持主导地位。这是由于 FDA 批准的伤口清创设备的存在以及不断增长的医疗保健支出将进一步推动该地区市场的增长率。此外，有利的健康补偿政策、慢性伤口的增加以及老龄人口的增长将进一步推动该地区市场的增长率。

由于亚太地区保险支付人数增加，预计该地区将成为 2023-2030 年预测期内增长最快的地区。此外，私营医疗保健行业的发展和人们意识的提高将进一步推动该地区市场的增长率。

The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points such as down-stream and up-stream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The non-surgical procedures market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for non-surgical procedures market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the non-surgical procedures market. The data is available for historic period 2015 to 2020

Competitive Landscape and Non-Surgical Procedures Market Share Analysis

The non-surgical procedures market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the company’s focus related to non-surgical procedures market.

Some of the major players operating in the non-surgical procedures market are:

• Bioha Laboratories (South Korea)
• Bohus BioTech AB (Sweden)
• Contura Ltd.(Switzerland)
• Laboratoires VIVACY (France)
• Merz Pharma (Germany)
• Prollenium Medical Technologies (Canada)
• Zhejiang Jingjia Medical Technology Co., LTD (China)
• Allergan (a subsidiary of AbbVie Inc.)(Ireland)
• Luminera (Israel)
• Medytox (South Korea)
• ADODERM GmbH (Germany)
• Azul Skin Health (U.S.)
• Bioxis pharmaceuticals (France)
• Croma Deutschland GmbH (Austria)
• Sinclair Pharma (U.K.)
• Suneva Medical (U.S.)
•  dr. brandt skincare (U.S.)
• DRMTLGY LLC (U.S.)
• Galderma (Switzerland)
• Johnson & Johnson Services, Inc.(U.S.)
• Krasr (U.S.)
• Mary Kay Inc.(U.S.)
• Rodan & Fields (U.S.)
• Teoxane SA (Switzerland)
• Dermaroller GmbH (Germany)
• Alma Lasers (Israel)
• BIOPLUS CO., LTD.(South Korea)
• BISON MEDICAL (South Korea)
• CHUNGWOO Medical Co., Ltd. (South Korea)
• Fotona (Slovenia)
• HUMEDIX.CO.LTD (South Korea)
• Weyergans High Care AG (Germany)
• SCULPT Luxury Dermal Fillers LTD (U.K.)

SKU-59661